HOXA9 and non-small cell lung carcinoma: On the other hand, Wen et al. reported a sensitivity of 75.0% and a specificity of 98.0% when detecting methylated HOXA9 in blood samples of NSCLC patients with methylated HOXA9 tumors [18].